Nine of 51 patients with early stage NAFLD were undergoing treatment for hypercholesterolemia with hydroxymethyl glutaryl coenzyme A reductase (HMG CoA-reductase) inhibitors; commonly called statins. Here, HMGCR is linked to familial hypercholesterolemia.